$36.24
0.832.34%
At Close: -
$36.24
00.00%
After Hours: Jul 5, 4:00 PM EDT
15 minutes delayed
Apellis Pharmaceuticals
APLSNASDAQ
Apellis Pharmaceuticals (NASDAQ:APLS) Stock, Insider Trading Activity
Apellis Pharmaceuticals: Insider buying and selling updated today.
Institutional Shares Held
68.564M
Institutional Percentage Held
56.5%
| Jun 21, 2024 | Sinclair A. Dunlop | — | -37K | $39.24 | -$1.45M | SELL | -17.97% | 168.853K | Jun 21 | View |
| May 09, 2024 | Pascal Deschatelets | CHIEF SCIENTIFIC OFFICER | 0 | $23.33 | -$3.00M | SELL-OPTIONS | 0.00% | 1.115983M | May 08 | View |
| Apr 09, 2024 | Pascal Deschatelets | CHIEF SCIENTIFIC OFFICER | 0 | $28.97 | -$3.48M | SELL-OPTIONS | 0.00% | 1.115983M | Apr 08 | View |
| Apr 02, 2024 | Timothy Sullivan | CHIEF FINANCIAL OFFICER | 0 | $34.34 | -$194.52K | SELL-OPTIONS | 0.00% | 149.57K | Apr 01 | View |
| Mar 20, 2024 | Sinclair A. Dunlop | — | -18.681K | $57.18 | -$1.07M | SELL | -8.32% | 205.853K | Mar 19 | View |
| Mar 19, 2024 | Mark DeLong | CHIEF BUSINESS & STRAT OFFICER | -9.913K | $56.90 | -$564.05K | SELL | -15.34% | 54.693K | Mar 18 | View |
| Mar 18, 2024 | James Chopas | VP/CHIEF ACCOUNTING OFFICER | -184 | $56.46 | -$10.39K | SELL | -0.47% | 38.883K | Mar 15 | View |
| Mar 14, 2024 | Nur Nicholson | CHIEF TECHNICAL OFFICER | -11.22K | $57.56 | -$645.84K | SELL | -16.62% | 56.287K | Mar 13 | View |
| Mar 11, 2024 | Pascal Deschatelets | CHIEF SCIENTIFIC OFFICER | 0 | $32.93 | -$4.04M | SELL-OPTIONS | 0.00% | 1.115983M | Mar 08 | View |
| Mar 05, 2024 | Cedric Francois | CHIEF EXECUTIVE OFFICER | 0 | $34.16 | -$14.98M | SELL-OPTIONS | 0.00% | 548.073K | Mar 01 | View |
| Mar 05, 2024 | Timothy Sullivan | CHIEF FINANCIAL OFFICER | 0 | $36.63 | -$319.16K | SELL-OPTIONS | 0.00% | 149.57K | Mar 01 | View |
| Feb 13, 2024 | David Watson | GENERAL COUNSEL | -781 | $67.77 | -$52.93K | SELL | -0.70% | 110.057K | Feb 12 | View |
| Feb 13, 2024 | Adam Townsend | CHIEF COMMERCIAL OFFICER | -1.148K | $67.77 | -$77.80K | SELL | -1.23% | 92.453K | Feb 12 | View |
| Feb 13, 2024 | Timothy Sullivan | CHIEF FINANCIAL OFFICER | -1.431K | $67.77 | -$96.97K | SELL | -0.95% | 149.57K | Feb 12 | View |
| Feb 13, 2024 | Cedric Francois | CHIEF EXECUTIVE OFFICER | -3.962K | $67.77 | -$268.49K | SELL | -0.72% | 548.073K | Feb 12 | View |
| Feb 13, 2024 | Pascal Deschatelets | CHIEF SCIENTIFIC OFFICER | -1.148K | $67.77 | -$77.80K | SELL | -0.10% | 1.115983M | Feb 12 | View |
| Feb 13, 2024 | Mark DeLong | CHIEF BUSINESS & STRAT OFFICER | -597 | $67.77 | -$40.46K | SELL | -0.92% | 64.606K | Feb 12 | View |
| Jan 31, 2024 | David Watson | GENERAL COUNSEL | -906 | $64.14 | -$58.11K | SELL | -0.81% | 110.838K | Jan 29 | View |
| Jan 31, 2024 | Adam Townsend | CHIEF COMMERCIAL OFFICER | -906 | $64.14 | -$58.11K | SELL | -0.96% | 93.601K | Jan 29 | View |
| Jan 31, 2024 | Timothy Sullivan | CHIEF FINANCIAL OFFICER | -906 | $64.14 | -$58.11K | SELL | -0.60% | 151.001K | Jan 29 | View |
| Jan 31, 2024 | Nur Nicholson | CHIEF TECHNICAL OFFICER | -835 | $64.14 | -$53.56K | SELL | -1.22% | 67.507K | Jan 29 | View |
| Jan 31, 2024 | Karen Lewis | CHIEF PEOPLE OFFICER | -1.25K | $65.12 | -$81.40K | SELL | -2.62% | 46.387K | Jan 29 - Jan 30 | View |
| Jan 31, 2024 | Cedric Francois | CHIEF EXECUTIVE OFFICER | -2.843K | $64.14 | -$182.34K | SELL | -0.51% | 552.035K | Jan 29 | View |
| Jan 31, 2024 | Jeffrey Eisele | CHIEF DEVELOPMENT OFFICER | -1.25K | $65.22 | -$81.52K | SELL | -2.14% | 57.208K | Jan 29 - Jan 30 | View |
| Jan 31, 2024 | Pascal Deschatelets | CHIEF SCIENTIFIC OFFICER | -874 | $64.14 | -$56.06K | SELL | -0.08% | 1.117131M | Jan 29 | View |
| Jan 31, 2024 | Mark DeLong | CHIEF BUSINESS & STRAT OFFICER | -367 | $64.14 | -$23.54K | SELL | -0.56% | 65.203K | Jan 29 | View |
| Jan 24, 2024 | Karen Lewis | CHIEF PEOPLE OFFICER | -4.286K | $63.69 | -$272.98K | SELL | -8.25% | 47.637K | Jan 23 | View |
| Jan 24, 2024 | Jeffrey Eisele | CHIEF DEVELOPMENT OFFICER | -7.378K | $63.69 | -$469.90K | SELL | -11.21% | 58.458K | Jan 23 | View |
| Jan 23, 2024 | Cedric Francois | CHIEF EXECUTIVE OFFICER | -13.431K | $65.00 | -$872.96K | SELL | -2.36% | 554.878K | Jan 22 | View |
| Jan 23, 2024 | David Watson | GENERAL COUNSEL | -4.184K | $65.00 | -$271.94K | SELL | -3.61% | 111.744K | Jan 22 | View |
| Jan 23, 2024 | Adam Townsend | CHIEF COMMERCIAL OFFICER | -3.413K | $65.00 | -$221.83K | SELL | -3.49% | 94.507K | Jan 22 | View |
| Jan 23, 2024 | Timothy Sullivan | CHIEF FINANCIAL OFFICER | -3.551K | $65.00 | -$230.80K | SELL | -2.28% | 151.907K | Jan 22 | View |
| Jan 23, 2024 | Nur Nicholson | CHIEF TECHNICAL OFFICER | -2.593K | $65.00 | -$168.53K | SELL | -3.66% | 68.342K | Jan 22 | View |
| Jan 23, 2024 | Karen Lewis | CHIEF PEOPLE OFFICER | -1.738K | $65.00 | -$112.96K | SELL | -3.24% | 51.923K | Jan 22 | View |
| Jan 23, 2024 | Jeffrey Eisele | CHIEF DEVELOPMENT OFFICER | -1.607K | $65.00 | -$104.45K | SELL | -2.38% | 65.836K | Jan 22 | View |
| Jan 23, 2024 | Pascal Deschatelets | CHIEF SCIENTIFIC OFFICER | -3.913K | $65.00 | -$254.33K | SELL | -0.35% | 1.118005M | Jan 22 | View |
| Jan 23, 2024 | Mark DeLong | CHIEF BUSINESS & STRAT OFFICER | -1.384K | $65.00 | -$89.95K | SELL | -2.07% | 65.57K | Jan 22 | View |
| Jan 23, 2024 | James Chopas | VP/CHIEF ACCOUNTING OFFICER | -1.061K | $65.00 | -$68.96K | SELL | -2.64% | 39.067K | Jan 22 | View |
| Jan 18, 2024 | Jeffrey Eisele | CHIEF DEVELOPMENT OFFICER | -5.207K | $65.58 | -$341.48K | SELL | -7.17% | 67.443K | Jan 17 | View |
| Jan 18, 2024 | Karen Lewis | CHIEF PEOPLE OFFICER | -3.276K | $65.58 | -$214.84K | SELL | -5.75% | 53.661K | Jan 17 | View |
| Jan 17, 2024 | Pascal Deschatelets | CHIEF SCIENTIFIC OFFICER | 5.111K | $66.81 | -$109.03K | GRANT | 0.46% | 1.121918M | Jan 16 | View |
| Jan 17, 2024 | James Chopas | VP/CHIEF ACCOUNTING OFFICER | 7.448K | $66.81 | -$57.72K | GRANT | 22.79% | 40.128K | Jan 16 | View |
| Jan 17, 2024 | Karen Lewis | CHIEF PEOPLE OFFICER | 15.331K | $66.81 | -$109.03K | GRANT | 36.85% | 56.937K | Jan 16 | View |
| Jan 17, 2024 | Mark DeLong | CHIEF BUSINESS & STRAT OFFICER | 15.332K | $66.81 | -$108.96K | GRANT | 29.70% | 66.954K | Jan 16 | View |
| Jan 17, 2024 | Nur Nicholson | CHIEF TECHNICAL OFFICER | 17.651K | $66.81 | -$124.06K | GRANT | 33.13% | 70.935K | Jan 16 | View |
| Jan 17, 2024 | David Watson | GENERAL COUNSEL | 19.508K | $66.81 | -$283.27K | GRANT | 20.23% | 115.928K | Jan 16 | View |
| Jan 17, 2024 | Adam Townsend | CHIEF COMMERCIAL OFFICER | 21.513K | $66.81 | -$149.32K | GRANT | 28.16% | 97.92K | Jan 16 | View |
| Jan 17, 2024 | Timothy Sullivan | CHIEF FINANCIAL OFFICER | 21.513K | $66.81 | -$149.32K | GRANT | 16.06% | 155.458K | Jan 16 | View |
| Jan 17, 2024 | Cedric Francois | CHIEF EXECUTIVE OFFICER | 64.243K | $66.81 | -$524.51K | GRANT | 12.74% | 568.309K | Jan 16 | View |
| Jan 17, 2024 | Jeffrey Eisele | CHIEF DEVELOPMENT OFFICER | 19.07K | $66.81 | -$29.26K | GRANT | 35.59% | 72.65K | Jan 16 | View |
| Jan 05, 2024 | Caroline Baumal | CHIEF MEDICAL OFFICER | -2.751K | $60.05 | -$165.21K | SELL | -7.71% | 32.93137K | Jan 04 | View |
| Dec 28, 2023 | Jeffrey Eisele | CHIEF DEVELOPMENT OFFICER | -303 | $59.70 | -$18.09K | SELL | -0.56% | 53.58K | Dec 26 - Dec 27 | View |
| Dec 20, 2023 | David Watson | GENERAL COUNSEL | 4K | $35.54 | -$113.99K | SELL-OPTIONS | 4.33% | 96.42K | Dec 19 | View |
| Dec 05, 2023 | Lukas Scheibler | CHIEF RESEARCH OFFICER | 0 | $36.92 | -$461.50K | SELL-OPTIONS | 0.00% | 68.299K | Dec 01 | View |
| Dec 05, 2023 | Adam Townsend | CHIEF COMMERCIAL OFFICER | 0 | $37.95 | -$5.03M | SELL-OPTIONS | 0.00% | 76.407K | Dec 01 | View |
| Dec 05, 2023 | Sinclair A. Dunlop | — | -24K | $61.13 | -$1.47M | SELL | -9.66% | 224.534K | Dec 01 | View |
| Dec 01, 2023 | Timothy Sullivan | CHIEF FINANCIAL OFFICER | 0 | $32.38 | -$632.88K | SELL-OPTIONS | 0.00% | 133.945K | Nov 30 | View |
| Nov 21, 2023 | Cedric Francois | CHIEF EXECUTIVE OFFICER | -5K | $48.80 | -$244.00K | SELL | -0.98% | 504.066K | Nov 21 | View |
| Nov 21, 2023 | Sinclair Dunlop | DIRECTOR | -8.894K | $49.99 | -$444.62K | SELL | -5.45% | 154.258K | Nov 17 | View |
| Nov 21, 2023 | Sinclair A. Dunlop | DIRECTOR | -24K | $49.00 | -$1.18M | SELL | -8.81% | 248.534K | Oct 17 | View |
| Nov 20, 2023 | Alec Machiels | DIRECTOR | 0 | $25.21 | -$56.34K | SELL-OPTIONS | 0.00% | 517.42K | Nov 17 | View |
| Nov 09, 2023 | Pascal Deschatelets | CHIEF SCIENTIFIC OFFICER | 5.494K | $24.97 | -$520.53K | SELL-OPTIONS | 0.52% | 1.071807M | Nov 08 | View |
| Oct 24, 2023 | James Chopas | VP/CHIEF ACCOUNTING OFFICER | -132 | $46.04 | -$6.08K | SELL | -0.40% | 32.68K | Oct 23 | View |
| Oct 24, 2023 | Mark DeLong | CHIEF BUSINESS & STRAT OFFICER | -131 | $46.04 | -$6.03K | SELL | -0.25% | 51.622K | Oct 23 | View |
| Oct 18, 2023 | Alec Machiels | DIRECTOR | 0 | $25.59 | -$57.29K | SELL-OPTIONS | 0.00% | 517.42K | Oct 17 | View |
| Oct 10, 2023 | Pascal Deschatelets | CHIEF SCIENTIFIC OFFICER | 6.5K | $21.53 | -$435.17K | SELL-OPTIONS | 0.61% | 1.066313M | Oct 09 | View |
| Sep 19, 2023 | Alec Machiels | DIRECTOR | 0 | $23.84 | -$52.91K | SELL-OPTIONS | 0.00% | 517.42K | Sep 18 | View |
| Sep 19, 2023 | Nur Nicholson | CHIEF TECHNICAL OFFICER | -10.631K | $37.01 | -$611.58K | SELL | -16.63% | 53.284K | Sep 18 | View |
| Sep 18, 2023 | Alec Machiels | DIRECTOR | 0 | $24.01 | -$53.34K | SELL-OPTIONS | 0.00% | 517.42K | Sep 15 | View |
| Sep 11, 2023 | Pascal Deschatelets | CHIEF SCIENTIFIC OFFICER | 6.5K | $22.77 | -$465.04K | SELL-OPTIONS | 0.62% | 1.059813M | Sep 08 | View |
| Sep 07, 2023 | Lukas Scheibler | CHIEF RESEARCH OFFICER | -1.756K | $43.01 | -$75.53K | SELL | -2.51% | 68.299K | Sep 06 | View |
| Sep 01, 2023 | James Chopas | VP/CHIEF ACCOUNTING OFFICER | -551 | $41.23 | -$22.72K | SELL | -1.79% | 30.312K | Aug 31 | View |
| Sep 01, 2023 | Cedric Francois | CHIEF EXECUTIVE OFFICER | 150K | $22.21 | -$5.46M | SELL-OPTIONS | 29.47% | 659.066K | Sep 01 | View |
| Aug 09, 2023 | Pascal Deschatelets | CHIEF SCIENTIFIC OFFICER | 6.5K | $13.16 | -$234.53K | SELL-OPTIONS | 0.62% | 1.053313M | Aug 08 | View |
| Jul 18, 2023 | Alec Machiels | DIRECTOR | 0 | $33.73 | -$77.65K | SELL-OPTIONS | 0.00% | 417.641K | Jul 17 | View |
| Jul 11, 2023 | Pascal Deschatelets | CHIEF SCIENTIFIC OFFICER | 6.5K | $43.61 | -$965.21K | SELL-OPTIONS | 0.62% | 1.046813M | Jul 10 | View |
| Jul 06, 2023 | David Watson | GENERAL COUNSEL | -8.51K | $89.98 | -$765.73K | SELL | -8.43% | 92.42K | Jul 03 | View |
| Jul 06, 2023 | Timothy Sullivan | CHIEF FINANCIAL OFFICER | 0 | $50.00 | -$541.93K | SELL-OPTIONS | 0.00% | 133.945K | Jul 03 | View |
| Jun 21, 2023 | Alec Machiels | DIRECTOR | 0 | $45.54 | -$107.17K | SELL-OPTIONS | 0.00% | 417.641K | Jun 20 | View |
| Jun 09, 2023 | Pascal Deschatelets | CHIEF SCIENTIFIC OFFICER | 6.5K | $47.01 | -$1.05M | SELL-OPTIONS | 0.63% | 1.040313M | Jun 08 | View |
| Jun 06, 2023 | Timothy Sullivan | CHIEF FINANCIAL OFFICER | 0 | $49.42 | -$5.50M | SELL-OPTIONS | 0.00% | 133.945K | Jun 05 | View |
| Jun 02, 2023 | Karen Lewis | CHIEF PEOPLE OFFICER | 0 | $60.05 | -$259.45K | SELL-OPTIONS | 0.00% | 41.504K | Jun 01 | View |
| May 18, 2023 | Alec Machiels | DIRECTOR | 0 | $45.66 | -$107.49K | SELL-OPTIONS | 0.00% | 417.641K | May 17 | View |
| May 18, 2023 | Cedric Francois | CHIEF EXECUTIVE OFFICER | 20K | $44.17 | -$2.44M | SELL-OPTIONS | 3.93% | 529.066K | May 16 - May 17 | View |
| May 09, 2023 | Pascal Deschatelets | CHIEF SCIENTIFIC OFFICER | 6.5K | $47.53 | -$1.06M | SELL-OPTIONS | 0.63% | 1.033813M | May 08 | View |
| May 04, 2023 | Adam Townsend | CHIEF COMMERCIAL OFFICER | 0 | $48.90 | -$338.10K | SELL-OPTIONS | 0.00% | 75.995K | May 03 | View |
| Apr 20, 2023 | Cedric Francois | CHIEF EXECUTIVE OFFICER | 20K | $42.35 | -$2.33M | SELL-OPTIONS | 2.29% | 892.012K | Apr 18 - Apr 19 | View |
| Apr 18, 2023 | Alec Machiels | DIRECTOR | 0 | $41.86 | -$97.97K | SELL-OPTIONS | 0.00% | 417.641K | Apr 17 | View |
| Apr 11, 2023 | Pascal Deschatelets | CHIEF SCIENTIFIC OFFICER | 6.5K | $40.44 | -$889.12K | SELL-OPTIONS | 0.64% | 1.027313M | Apr 10 | View |
| Apr 05, 2023 | Sinclair Dunlop | DIRECTOR | -500 | $74.05 | -$37.02K | SELL | -0.31% | 163.152K | Apr 03 | View |
| Apr 05, 2023 | Karen Lewis | CHIEF PEOPLE OFFICER | 0 | $54.55 | -$204.45K | SELL-OPTIONS | 0.00% | 41.43K | Apr 03 | View |
| Apr 05, 2023 | Adam Townsend | CHIEF COMMERCIAL OFFICER | 0 | $44.57 | -$294.80K | SELL-OPTIONS | 0.00% | 75.995K | Apr 03 | View |
| Mar 23, 2023 | Cedric Francois | CHIEF EXECUTIVE OFFICER | 127.221K | $33.31 | -$1.27M | SELL-OPTIONS | 9.23% | 1.506223M | Mar 21 - Mar 22 | View |
| Mar 21, 2023 | Alec Machiels | DIRECTOR | 0 | $33.35 | -$76.70K | SELL-OPTIONS | 0.00% | 417.641K | Mar 17 | View |
| Mar 10, 2023 | Pascal Deschatelets | CHIEF SCIENTIFIC OFFICER | 6.5K | $33.23 | -$716.09K | SELL-OPTIONS | 0.64% | 1.020813M | Mar 08 | View |
| Mar 07, 2023 | Adam Townsend | CHIEF COMMERCIAL OFFICER | 0 | $39.47 | -$243.75K | SELL-OPTIONS | 0.00% | 75.995K | Mar 03 | View |
| Mar 02, 2023 | Sinclair Dunlop | DIRECTOR | -500 | $65.33 | -$32.66K | SELL | -0.30% | 163.652K | Mar 01 | View |
| Feb 27, 2023 | Jeffrey Eisele | CHIEF DEVELOPMENT OFFICER | -1.646K | $68.76 | -$113.18K | SELL | -2.96% | 53.883K | Feb 23 | View |
| Feb 27, 2023 | Karen Lewis | CHIEF PEOPLE OFFICER | -1.104K | $68.76 | -$75.91K | SELL | -2.60% | 41.43K | Feb 23 | View |
| Feb 21, 2023 | Alec Machiels | DIRECTOR | 0 | $27.53 | -$62.14K | SELL-OPTIONS | 0.00% | 417.641K | Feb 17 | View |
| Feb 10, 2023 | Pascal Deschatelets | CHIEF SCIENTIFIC OFFICER | 6.5K | $28.56 | -$604.00K | SELL-OPTIONS | 0.65% | 1.006756M | Feb 08 | View |
| Feb 06, 2023 | Adam Townsend | CHIEF COMMERCIAL OFFICER | 0 | $35.47 | -$203.80K | SELL-OPTIONS | 0.00% | 67.932K | Feb 03 | View |
| Feb 02, 2023 | Sinclair Dunlop | DIRECTOR | -500 | $52.61 | -$26.30K | SELL | -0.30% | 164.152K | Feb 01 | View |
| Jan 31, 2023 | Jeffrey Eisele | CHIEF DEVELOPMENT OFFICER | -883 | $52.76 | -$46.59K | SELL | -1.86% | 46.468K | Jan 30 | View |
| Jan 31, 2023 | Karen Lewis | CHIEF PEOPLE OFFICER | -883 | $52.76 | -$46.59K | SELL | -2.36% | 36.459K | Jan 30 | View |
| Jan 25, 2023 | Karen Lewis | CHIEF PEOPLE OFFICER | -2.955K | $51.58 | -$152.42K | SELL | -7.27% | 37.709K | Jan 23 | View |
| Jan 25, 2023 | Jeffrey Eisele | CHIEF DEVELOPMENT OFFICER | -4.479K | $51.58 | -$231.03K | SELL | -8.58% | 47.718K | Jan 23 | View |
| Jan 19, 2023 | Alec Machiels | DIRECTOR | 0 | $27.55 | -$62.19K | SELL-OPTIONS | 0.00% | 417.641K | Jan 17 | View |
| Jan 10, 2023 | Pascal Deschatelets | CHIEF SCIENTIFIC OFFICER | 6.5K | $24.38 | -$503.56K | SELL-OPTIONS | 0.67% | 983.78K | Jan 09 | View |
| Jan 09, 2023 | Federico Grossi | CHIEF MEDICAL OFFICER | -2.5K | $48.79 | -$121.97K | SELL | -2.57% | 94.884K | Jan 05 | View |
| Jan 05, 2023 | Adam Townsend | CHIEF COMMERCIAL OFFICER | 0 | $32.90 | -$178.05K | SELL-OPTIONS | 0.00% | 42.907K | Jan 03 | View |
| Jan 05, 2023 | Sinclair Dunlop | DIRECTOR | -500 | $50.70 | -$25.35K | SELL | -0.30% | 164.652K | Jan 03 | View |
| Dec 21, 2022 | Cedric Francois | CHIEF EXECUTIVE OFFICER | 9.188K | $28.35 | -$1.24M | SELL-OPTIONS | 0.77% | 1.199539M | Apr 25 - Dec 19 | View |
| Dec 19, 2022 | Alec Machiels | DIRECTOR | 0 | $27.51 | -$62.10K | SELL-OPTIONS | 0.00% | 413.774K | Dec 15 | View |
| Dec 12, 2022 | Pascal Deschatelets | CHIEF SCIENTIFIC OFFICER | 6.5K | $25.09 | -$520.61K | SELL-OPTIONS | 0.67% | 970.28K | Dec 08 | View |
| Dec 07, 2022 | Adam Townsend | CHIEF COMMERCIAL OFFICER | -10K | $32.73 | -$327.35K | SELL | -18.90% | 42.907K | Dec 05 | View |
| Dec 02, 2022 | Sinclair Dunlop | DIRECTOR | -500 | $49.93 | -$24.96K | SELL | -0.31% | 161.285K | Dec 01 | View |
| Dec 02, 2022 | Federico Grossi | CHIEF MEDICAL OFFICER | -2.5K | $49.93 | -$124.83K | SELL | -2.50% | 97.384K | Dec 01 | View |
| Nov 17, 2022 | Alec Machiels | DIRECTOR | 0 | $25.34 | -$56.67K | SELL-OPTIONS | 0.00% | 413.774K | Nov 15 | View |
| Nov 10, 2022 | Pascal Deschatelets | CHIEF SCIENTIFIC OFFICER | 6.5K | $24.57 | -$508.25K | SELL-OPTIONS | 0.68% | 963.78K | Nov 08 | View |
| Nov 07, 2022 | Adam Townsend | CHIEF COMMERCIAL OFFICER | -10K | $36.81 | -$368.15K | SELL | -18.90% | 42.907K | Nov 03 | View |
| Nov 03, 2022 | Sinclair Dunlop | DIRECTOR | -500 | $60.83 | -$30.41K | SELL | -0.31% | 161.785K | Nov 01 | View |
| Nov 03, 2022 | Federico Grossi | CHIEF MEDICAL OFFICER | -2.5K | $60.83 | -$152.07K | SELL | -2.44% | 99.884K | Nov 01 | View |
| Oct 17, 2022 | Alec Machiels | DIRECTOR | 0 | $30.99 | -$70.80K | SELL-OPTIONS | 0.00% | 413.774K | Oct 14 | View |
| Oct 11, 2022 | Pascal Deschatelets | CHIEF SCIENTIFIC OFFICER | 6.5K | $30.09 | -$640.61K | SELL-OPTIONS | 0.68% | 957.28K | Oct 10 | View |
| Oct 05, 2022 | Federico Grossi | CHIEF MEDICAL OFFICER | -2.5K | $66.69 | -$166.72K | SELL | -2.38% | 102.384K | Oct 03 | View |
| Oct 05, 2022 | Adam Townsend | CHIEF COMMERCIAL OFFICER | 0 | $40.89 | -$258.00K | SELL-OPTIONS | 0.00% | 42.907K | Oct 03 | View |
| Sep 16, 2022 | Alec Machiels | DIRECTOR | 0 | $34.34 | -$79.16K | SELL-OPTIONS | 0.00% | 413.774K | Sep 15 | View |
| Sep 12, 2022 | Pascal Deschatelets | CHIEF SCIENTIFIC OFFICER | 6.5K | $33.32 | -$718.37K | SELL-OPTIONS | 0.69% | 950.78K | Sep 08 | View |
| Sep 08, 2022 | Sinclair Dunlop | DIRECTOR | -15K | $65.00 | -$975.00K | SELL | -5.22% | 272.534K | Sep 08 | View |
| Sep 07, 2022 | Adam Townsend | CHIEF COMMERCIAL OFFICER | 0 | $37.73 | -$226.45K | SELL-OPTIONS | 0.00% | 42.907K | Sep 06 | View |
| Sep 02, 2022 | Federico Grossi | CHIEF MEDICAL OFFICER | -2.5K | $60.30 | -$150.75K | SELL | -2.33% | 104.884K | Sep 01 | View |
| Aug 18, 2022 | Mark Delong | SENIOR VICE PRESIDENT | 0 | $42.51 | -$269.90K | SELL-OPTIONS | 0.00% | 29.25K | Aug 17 | View |
| Aug 16, 2022 | Adam Townsend | CHIEF COMMERCIAL OFFICER | 0 | $42.05 | -$673.88K | SELL-OPTIONS | 0.00% | 42.907K | Aug 15 | View |
| Aug 16, 2022 | Alec Machiels | DIRECTOR | 0 | $34.94 | -$80.67K | SELL-OPTIONS | 0.00% | 413.774K | Aug 15 | View |
| Aug 12, 2022 | Adam Townsend | CHIEF COMMERCIAL OFFICER | 0 | $41.05 | -$648.88K | SELL-OPTIONS | 0.00% | 42.907K | Aug 11 | View |
| Aug 12, 2022 | Mark Delong | SENIOR VICE PRESIDENT | 0 | $41.26 | -$257.40K | SELL-OPTIONS | 0.00% | 29.25K | Aug 11 | View |
| Aug 12, 2022 | Sinclair Dunlop | DIRECTOR | -30K | $65.63 | -$1.97M | SELL | -9.45% | 287.534K | Aug 11 | View |
| Aug 09, 2022 | Adam Townsend | CHIEF COMMERCIAL OFFICER | 0 | $40.05 | -$623.88K | SELL-OPTIONS | 0.00% | 42.907K | Aug 08 | View |
| Aug 09, 2022 | Pascal Deschatelets | CHIEF SCIENTIFIC OFFICER | 6.5K | $32.59 | -$700.61K | SELL-OPTIONS | 0.69% | 944.28K | Aug 08 | View |
| Aug 09, 2022 | Mark Delong | SENIOR VICE PRESIDENT | 0 | $40.01 | -$244.90K | SELL-OPTIONS | 0.00% | 29.25K | Aug 08 | View |
| Aug 08, 2022 | Mark Delong | SENIOR VICE PRESIDENT | 0 | $38.13 | -$452.30K | SELL-OPTIONS | 0.00% | 29.25K | Aug 04 | View |
| Aug 04, 2022 | Adam Townsend | CHIEF COMMERCIAL OFFICER | 0 | $35.76 | -$206.70K | SELL-OPTIONS | 0.00% | 42.907K | Aug 03 | View |
| Aug 02, 2022 | Federico Grossi | CHIEF MEDICAL OFFICER | -2.5K | $55.99 | -$139.97K | SELL | -2.28% | 107.384K | Aug 01 | View |
| Jul 28, 2022 | Mark Delong | SENIOR VICE PRESIDENT | 0 | $36.26 | -$207.40K | SELL-OPTIONS | 0.00% | 29.25K | Jul 27 | View |
| Jul 21, 2022 | Mark Delong | SENIOR VICE PRESIDENT | 0 | $35.97 | -$204.50K | SELL-OPTIONS | 0.00% | 29.25K | Jul 19 | View |
| Jul 18, 2022 | Alec Machiels | DIRECTOR | 0 | $24.50 | -$54.58K | SELL-OPTIONS | 0.00% | 413.774K | Jul 15 | View |
| Jul 12, 2022 | Adam Townsend | CHIEF COMMERCIAL OFFICER | -1.875K | $31.76 | -$166.65K | SELL | -4.19% | 42.907K | Apr 21 - Jul 11 | View |
| Jul 12, 2022 | Pascal Deschatelets | CHIEF SCIENTIFIC OFFICER | 6.5K | $25.31 | -$526.00K | SELL-OPTIONS | 0.70% | 937.78K | Jul 08 | View |
| Jun 29, 2022 | A. Sinclair Dunlop | DIRECTOR | -1.341K | $46.79 | -$62.74K | SELL | -0.47% | 287.022K | Jun 27 | View |
| Jun 24, 2022 | A. Sinclair Dunlop | DIRECTOR | -15K | $45.00 | -$675.00K | SELL | -4.99% | 285.679K | Jun 23 | View |
| Jun 23, 2022 | David Watson | GENERAL COUNSEL | -10K | $44.51 | -$445.14K | SELL | -7.56% | 122.236K | Jun 22 | View |
| Jun 22, 2022 | Victoria Brown | PROGRAM TEAM LEAD | -2.698K | $45.00 | -$121.41K | SELL | -9.75% | 24.974K | Jun 17 | View |
| Jun 21, 2022 | Mark Delong | SENIOR VICE PRESIDENT | 0 | $27.82 | -$279.35K | SELL-OPTIONS | 0.00% | 29.25K | Jun 16 | View |
| Jun 17, 2022 | Alec Machiels | DIRECTOR | 0 | $20.98 | -$45.77K | SELL-OPTIONS | 0.00% | 413.774K | Jun 15 | View |
| Jun 09, 2022 | Pascal Deschatelets | CHIEF SCIENTIFIC OFFICER | 6.5K | $23.38 | -$479.69K | SELL-OPTIONS | 0.73% | 898.275K | Jun 08 | View |
| Jun 02, 2022 | Federico Grossi | CHIEF MEDICAL OFFICER | -2.5K | $41.78 | -$104.45K | SELL | -2.23% | 109.561K | Jun 01 | View |
| May 31, 2022 | Lukas Scheibler | CHIEF INNOVATION OFFICER | -11.875K | $43.00 | -$430.00K | SELL | -22.73% | 40.358K | Apr 21 - May 27 | View |
| May 17, 2022 | Alec Machiels | DIRECTOR | 0 | $20.93 | -$45.64K | SELL-OPTIONS | 0.00% | 413.774K | May 16 | View |
| May 03, 2022 | Federico Grossi | CHIEF MEDICAL OFFICER | -4.375K | $43.56 | -$108.90K | SELL | -3.76% | 112.061K | Apr 21 - May 02 | View |
| May 02, 2022 | Pascal Deschatelets | CHIEF SCIENTIFIC OFFICER | -1.875K | $23.55 | -$167.04K | SELL | -0.21% | 891.775K | Apr 21 - Apr 29 | View |
| Apr 27, 2022 | David Watson | GENERAL COUNSEL | -6.875K | $50.00 | -$250.00K | SELL | -4.94% | 132.236K | Apr 21 - Apr 25 | View |
| Apr 22, 2022 | Mark Delong | SENIOR VICE PRESIDENT | 0 | $34.02 | -$259.07K | SELL-OPTIONS | 0.00% | 28.481K | Apr 20 | View |
| Apr 18, 2022 | Alec Machiels | DIRECTOR | 0 | $26.79 | -$60.29K | SELL-OPTIONS | 0.00% | 413.774K | Apr 14 | View |
| Apr 06, 2022 | Lukas Scheibler | CHIEF INNOVATION OFFICER | 0 | $36.97 | -$28.16K | SELL-OPTIONS | 0.00% | 52.233K | Apr 05 | View |
| Apr 05, 2022 | Lukas Scheibler | CHIEF INNOVATION OFFICER | 0 | $35.41 | -$151.06K | SELL-OPTIONS | 0.00% | 52.233K | Apr 04 | View |
| Apr 04, 2022 | Lukas Scheibler | CHIEF INNOVATION OFFICER | 0 | $34.45 | -$473.64K | SELL-OPTIONS | 0.00% | 52.233K | Apr 01 | View |
| Mar 17, 2022 | Alec Machiels | DIRECTOR | 0 | $21.12 | -$46.13K | SELL-OPTIONS | 0.00% | 409.544K | Mar 15 | View |
| Mar 17, 2022 | Federico Grossi | CHIEF MEDICAL OFFICER | 6.625K | $21.94 | $15.33K | SELL-OPTIONS | 6.03% | 116.436K | Mar 15 | View |
| Mar 02, 2022 | Federico Grossi | CHIEF MEDICAL OFFICER | -375 | $43.53 | -$16.32K | SELL | -0.34% | 109.811K | Mar 01 | View |
| Feb 16, 2022 | Federico Grossi | CHIEF MEDICAL OFFICER | -375 | $45.43 | -$17.04K | SELL | -0.35% | 106.086K | Feb 15 | View |
| Feb 16, 2022 | Alec Machiels | DIRECTOR | 0 | $24.05 | -$53.45K | SELL-OPTIONS | 0.00% | 675.724K | Feb 15 | View |
| Feb 14, 2022 | Lukas Scheibler | CHIEF INNOVATION OFFICER | -1.666K | $46.80 | -$77.97K | SELL | -3.13% | 51.513K | Feb 11 | View |
| Feb 14, 2022 | Lukas Scheibler | CHIEF INNOVATION OFFICER | -678 | $31.83 | -$393.45K | SELL | -1.26% | 53.179K | Feb 10 | View |
| Feb 10, 2022 | Lukas Scheibler | CHIEF INNOVATION OFFICER | 0 | $29.43 | -$311.50K | SELL-OPTIONS | 0.00% | 53.857K | Feb 08 | View |
| Feb 02, 2022 | Federico Grossi | CHIEF MEDICAL OFFICER | -375 | $40.58 | -$15.22K | SELL | -0.36% | 103.566K | Feb 01 | View |
| Feb 01, 2022 | Lukas Scheibler | CHIEF INNOVATION OFFICER | -1.875K | $38.51 | -$72.21K | SELL | -3.36% | 53.857K | Jan 28 - Jan 31 | View |
| Jan 19, 2022 | Alec Machiels | DIRECTOR | 0 | $21.62 | -$47.36K | SELL-OPTIONS | 0.00% | 675.724K | Jan 14 | View |
| Jan 19, 2022 | Federico Grossi | CHIEF MEDICAL OFFICER | 3.025K | $22.44 | -$556.00 | SELL-OPTIONS | 4.01% | 78.54K | Jan 14 | View |
| Jan 04, 2022 | Federico Grossi | CHIEF MEDICAL OFFICER | -375 | $47.31 | -$17.74K | SELL | -0.53% | 70.354K | Jan 03 | View |
| Dec 28, 2021 | David Watson | GENERAL COUNSEL | -1.2K | $48.50 | -$58.20K | SELL | -1.01% | 117.534K | Dec 27 | View |
| Dec 23, 2021 | David Watson | GENERAL COUNSEL | 9.541K | $31.11 | -$215.70K | SELL-OPTIONS | 8.74% | 118.734K | Dec 22 | View |
| Dec 17, 2021 | Federico Grossi | CHIEF MEDICAL OFFICER | -375 | $42.88 | -$16.08K | SELL | -0.53% | 70.729K | Dec 15 | View |
| Dec 17, 2021 | Alec Machiels | DIRECTOR | 0 | $22.78 | -$120.63K | SELL-OPTIONS | 0.00% | 671.494K | Dec 15 | View |
| Dec 03, 2021 | Federico Grossi | CHIEF MEDICAL OFFICER | -375 | $42.40 | -$15.90K | SELL | -0.58% | 64.104K | Dec 01 | View |
| Nov 18, 2021 | Morningside Venture Investments Ltd | 10% OWNER | 250K | $40.00 | $10.00M | BUY | 1.99% | 12.806342M | Nov 18 | View |
| Nov 17, 2021 | Federico Grossi | CHIEF MEDICAL OFFICER | -625 | $43.50 | -$27.19K | SELL | -0.96% | 64.479K | Nov 15 | View |
| Nov 17, 2021 | Alec Machiels | DIRECTOR | 0 | $20.96 | -$219.48K | SELL-OPTIONS | 0.00% | 671.494K | Nov 04 - Nov 15 | View |
| Nov 02, 2021 | Federico Grossi | CHIEF MEDICAL OFFICER | -625 | $30.70 | -$19.19K | SELL | -0.96% | 64.805K | Nov 01 | View |
| Oct 15, 2021 | Federico Grossi | CHIEF MEDICAL OFFICER | -750 | $34.57 | -$25.93K | SELL | -1.13% | 65.43K | Oct 14 | View |
| Oct 05, 2021 | Federico Grossi | CHIEF MEDICAL OFFICER | -750 | $33.26 | -$24.95K | SELL | -1.12% | 66.18K | Oct 01 | View |
| Aug 17, 2021 | Alec Machiels | DIRECTOR | 0 | $29.81 | -$135.70K | SELL-OPTIONS | 0.00% | 671.494K | Aug 16 | View |
| Aug 03, 2021 | Federico Grossi | CHIEF MEDICAL OFFICER | -250 | $63.99 | -$16.00K | SELL | -0.40% | 62.93K | Aug 02 | View |
| Aug 03, 2021 | Nicole Perry | VICE PRESIDENT - ACCOUNTING | 0 | $33.88 | -$60.23K | SELL-OPTIONS | 0.00% | 4.847K | Aug 02 | View |
| Jul 22, 2021 | Mark Delong | SENIOR VICE PRESIDENT | 0 | $40.26 | -$49.48K | SELL-OPTIONS | 0.00% | 9.49K | Jul 21 | View |
| Jul 16, 2021 | Mark Delong | SENIOR VICE PRESIDENT | 0 | $38.91 | -$46.78K | SELL-OPTIONS | 0.00% | 9.49K | Jul 15 | View |
| Jul 16, 2021 | Alec Machiels | DIRECTOR | 0 | $32.48 | -$149.07K | SELL-OPTIONS | 0.00% | 671.494K | Jul 15 | View |
| Jul 15, 2021 | Federico Grossi | CHIEF MEDICAL OFFICER | -500 | $64.68 | -$32.34K | SELL | -0.79% | 63.18K | Jul 14 | View |
| Jul 09, 2021 | Federico Grossi | CHIEF MEDICAL OFFICER | -250 | $65.68 | -$16.42K | SELL | -0.39% | 63.68K | Jul 08 | View |
| Jul 02, 2021 | Nicole Perry | VICE PRESIDENT - ACCOUNTING | 0 | $33.88 | -$60.24K | SELL-OPTIONS | 0.00% | 4.847K | Jul 01 | View |
| Jun 25, 2021 | Pascal Deschatelets | CHIEF SCIENTIFIC OFFICER | 0 | $34.14 | -$393.38K | SELL-OPTIONS | 0.00% | 869.587K | Jun 24 | View |
| Jun 16, 2021 | Alec Machiels | DIRECTOR | 0 | $33.75 | -$155.40K | SELL-OPTIONS | 0.00% | 671.494K | Jun 15 | View |
| Jun 16, 2021 | Mark Delong | SENIOR VICE PRESIDENT | 0 | $40.24 | -$197.75K | SELL-OPTIONS | 0.00% | 9.49K | Jun 15 | View |
| Jun 15, 2021 | Nicole Perry | VICE PRESIDENT - ACCOUNTING | 0 | $32.38 | -$58.35K | SELL-OPTIONS | 0.00% | 4.847K | Jun 11 | View |
| Jun 15, 2021 | Federico Grossi | CHIEF MEDICAL OFFICER | -500 | $61.84 | -$30.92K | SELL | -0.90% | 54.93K | Jun 14 | View |
| Jun 11, 2021 | Lukas Scheibler | CHIEF INNOVATION OFFICER | -3.417K | $60.00 | -$205.02K | SELL | -11.36% | 26.651K | Jun 10 | View |
| Jun 02, 2021 | Nicole Perry | VICE PRESIDENT - ACCOUNTING | 0 | $30.08 | -$52.64K | SELL-OPTIONS | 0.00% | 4.847K | Jun 01 | View |
| May 25, 2021 | Pascal Deschatelets | CHIEF SCIENTIFIC OFFICER | 0 | $25.04 | -$279.56K | SELL-OPTIONS | 0.00% | 869.587K | May 24 | View |
| May 20, 2021 | A. Sinclair Dunlop | DIRECTOR | -162.873K | $52.54 | -$8.56M | SELL | -83.64% | 31.855K | May 18 - May 20 | View |
| May 19, 2021 | Mark Delong | SENIOR VICE PRESIDENT | 0 | $35.26 | -$78.96K | SELL-OPTIONS | 0.00% | 9.49K | May 18 | View |
| May 18, 2021 | Federico Grossi | CHIEF MEDICAL OFFICER | -500 | $45.39 | -$22.70K | SELL | -0.89% | 55.43K | May 14 | View |
| May 18, 2021 | Alec Machiels | DIRECTOR | 0 | $24.03 | -$106.80K | SELL-OPTIONS | 0.00% | 671.494K | May 14 | View |
| May 04, 2021 | Nicole Perry | VICE PRESIDENT - ACCOUNTING | 0 | $27.24 | -$46.97K | SELL-OPTIONS | 0.00% | 4.847K | May 03 | View |
| May 04, 2021 | Federico Grossi | CHIEF MEDICAL OFFICER | -600 | $50.73 | -$30.44K | SELL | -1.07% | 55.614K | May 03 | View |
| May 03, 2021 | Nicole Perry | VICE PRESIDENT - ACCOUNTING | 0 | $26.88 | -$46.24K | SELL-OPTIONS | 0.00% | 4.847K | Apr 30 | View |
| Apr 26, 2021 | Pascal Deschatelets | CHIEF SCIENTIFIC OFFICER | 0 | $24.40 | -$271.63K | SELL-OPTIONS | 0.00% | 865.087K | Apr 23 | View |
| Apr 22, 2021 | Alec Machiels | DIRECTOR | 0 | $24.21 | -$107.72K | SELL-OPTIONS | 0.00% | 671.494K | Apr 21 | View |
| Apr 15, 2021 | Federico Grossi | CHIEF MEDICAL OFFICER | -500 | $42.82 | -$21.41K | SELL | -0.88% | 56.214K | Apr 14 | View |
| Apr 05, 2021 | Federico Grossi | CHIEF MEDICAL OFFICER | -600 | $43.41 | -$26.05K | SELL | -1.05% | 56.714K | Apr 01 | View |
| Mar 17, 2021 | Alec Machiels | DIRECTOR | 0 | $24.72 | -$110.25K | SELL-OPTIONS | 0.00% | 671.494K | Mar 15 | View |
| Mar 17, 2021 | Federico Grossi | CHIEF MEDICAL OFFICER | -500 | $46.77 | -$23.39K | SELL | -0.86% | 57.314K | Mar 15 | View |
| Mar 11, 2021 | Pascal Deschatelets | CHIEF SCIENTIFIC OFFICER | 0 | $26.71 | -$300.44K | SELL-OPTIONS | 0.00% | 865.087K | Mar 10 | View |
| Mar 08, 2021 | Federico Grossi | CHIEF MEDICAL OFFICER | 0 | $25.91 | -$227.07K | SELL-OPTIONS | 0.00% | 57.814K | Mar 05 | View |
| Mar 03, 2021 | Nicole Perry | VICE PRESIDENT - ACCOUNTING | 0 | $26.88 | -$92.48K | SELL-OPTIONS | 0.00% | 2.347K | Mar 01 | View |
| Mar 03, 2021 | Federico Grossi | CHIEF MEDICAL OFFICER | -600 | $48.58 | -$29.15K | SELL | -1.03% | 57.814K | Mar 01 | View |
| Feb 17, 2021 | Federico Grossi | CHIEF MEDICAL OFFICER | -500 | $46.00 | -$23.00K | SELL | -0.85% | 58.414K | Feb 16 | View |
| Feb 17, 2021 | Alec Machiels | DIRECTOR | 0 | $24.34 | -$108.33K | SELL-OPTIONS | 0.00% | 671.494K | Feb 16 | View |
| Feb 10, 2021 | Nicole Perry | VICE PRESIDENT - ACCOUNTING | 0 | $26.88 | -$92.48K | SELL-OPTIONS | 0.00% | 2.5K | Feb 09 | View |
| Feb 02, 2021 | Federico Grossi | CHIEF MEDICAL OFFICER | -600 | $44.00 | -$26.40K | SELL | -1.00% | 59.602K | Feb 01 | View |
| Jan 19, 2021 | Alec Machiels | DIRECTOR | 0 | $27.91 | -$126.20K | SELL-OPTIONS | 0.00% | 671.494K | Jan 15 | View |
| Jan 15, 2021 | Federico Grossi | CHIEF MEDICAL OFFICER | -4K | $51.99 | -$207.96K | SELL | -10.04% | 35.827K | Jan 14 | View |
| Jan 05, 2021 | Federico Grossi | CHIEF MEDICAL OFFICER | -600 | $57.24 | -$34.34K | SELL | -1.48% | 39.827K | Jan 04 | View |
| Jan 05, 2021 | Nicole Perry | VICE PRESIDENT - ACCOUNTING | 0 | $30.50 | -$106.96K | SELL-OPTIONS | 0.00% | 0 | Jan 04 | View |
| Dec 16, 2020 | Alec Machiels | — | 0 | $27.41 | -$123.72K | OPTION EXERCISE | 0.00% | 671.494K | Dec 15 | View |
| Dec 16, 2020 | Cedric Francois | — | -5K | $52.16 | -$260.80K | SELL | -0.37% | 1.34749M | Dec 15 | View |
| Dec 15, 2020 | A. Sinclair Dunlop | — | -25K | $54.67 | -$1.37M | SELL | -12.52% | 174.728K | Dec 14 | View |
| Dec 15, 2020 | David Watson | — | 0 | $32.40 | -$680.04K | OPTION EXERCISE | 0.00% | 53.404K | Dec 11 - Dec 14 | View |
| Dec 08, 2020 | Nicole Perry | — | 0 | $26.88 | -$832.32K | OPTION EXERCISE | 0.00% | 0 | Dec 04 | View |
| Dec 07, 2020 | A. Sinclair Dunlop | — | -25K | $50.59 | -$1.26M | SELL | -11.12% | 199.728K | Dec 04 - Dec 07 | View |
| Dec 02, 2020 | Federico Grossi | — | -600 | $48.25 | -$28.95K | SELL | -1.78% | 33.177K | Dec 01 | View |
| Nov 17, 2020 | Cedric Francois | — | -5K | $39.38 | -$196.90K | SELL | -0.38% | 1.31249M | Nov 16 | View |
| Nov 17, 2020 | Alec Machiels | — | 0 | $21.03 | -$91.78K | OPTION EXERCISE | 0.00% | 671.494K | Nov 16 | View |
| Nov 03, 2020 | Federico Grossi | — | -600 | $31.09 | -$18.65K | SELL | -2.12% | 27.725K | Nov 02 | View |
| Oct 16, 2020 | Alec Machiels | — | 0 | $18.84 | -$80.83K | OPTION EXERCISE | 0.00% | 671.494K | Oct 15 | View |
| Oct 16, 2020 | Cedric Francois | — | -5K | $34.46 | -$172.30K | SELL | -0.38% | 1.31749M | Oct 15 | View |
| Oct 09, 2020 | Alec Machiels | — | 0 | $18.84 | -$242.47K | OPTION EXERCISE | 0.00% | 671.494K | Oct 07 | View |
| Oct 09, 2020 | Victoria Brown | — | 0 | $26.99 | -$192.24K | OPTION EXERCISE | 0.00% | 3.607K | Oct 07 | View |
| Oct 02, 2020 | Federico Grossi | — | -600 | $30.22 | -$18.13K | SELL | -2.07% | 28.325K | Oct 01 | View |
| Sep 16, 2020 | Cedric Francois | — | -5K | $30.96 | -$154.80K | SELL | -0.38% | 1.32249M | Sep 15 | View |
| Sep 02, 2020 | Federico Grossi | — | -600 | $31.58 | -$18.95K | SELL | -2.03% | 28.925K | Sep 01 | View |
| Aug 21, 2020 | Cedric Francois | — | -3.457K | $30.00 | -$103.71K | SELL | -0.26% | 1.32749M | Aug 20 | View |
| Aug 20, 2020 | Cedric Francois | — | -1.543K | $30.00 | -$46.29K | SELL | -0.12% | 1.330947M | Aug 18 | View |
| Aug 05, 2020 | Federico Grossi | — | -600 | $26.28 | -$15.77K | SELL | -1.99% | 29.525K | Aug 03 | View |
| Jul 16, 2020 | Cedric Francois | — | -5K | $32.12 | -$160.60K | SELL | -0.37% | 1.33249M | Jul 15 | View |
| Jul 02, 2020 | Federico Grossi | — | -850 | $32.43 | -$27.57K | SELL | -2.74% | 30.125K | Jul 01 | View |
| Jun 16, 2020 | Federico Grossi | — | -856 | $30.21 | -$25.86K | SELL | -2.69% | 30.975K | Jun 15 | View |
| Jun 16, 2020 | Alec Machiels | — | 0 | $16.44 | -$68.85K | OPTION EXERCISE | 0.00% | 671.494K | Jun 15 | View |
| Jun 16, 2020 | Cedric Francois | — | -5K | $30.21 | -$151.05K | SELL | -0.37% | 1.33749M | Jun 15 | View |
| May 19, 2020 | Cedric Francois | — | -5K | $29.92 | -$149.60K | SELL | -0.37% | 1.34249M | May 15 | View |
| May 19, 2020 | Alec Machiels | — | 0 | $16.34 | -$68.33K | OPTION EXERCISE | 0.00% | 671.494K | May 15 | View |
| May 12, 2020 | Paul Fonteyne | — | 5K | $31.81 | $159.03K | PURCHASE | ∞ | 5K | May 08 | View |
| Apr 17, 2020 | Cedric Francois | — | -5K | $29.77 | -$148.85K | SELL | -0.37% | 1.34749M | Apr 15 | View |
| Apr 17, 2020 | Alec Machiels | — | 0 | $16.34 | -$68.33K | OPTION EXERCISE | 0.00% | 671.494K | Apr 15 | View |
| Mar 26, 2020 | Alec Machiels | — | 0 | $16.34 | -$68.33K | OPTION EXERCISE | 0.00% | 671.494K | Mar 25 | View |
| Mar 18, 2020 | Cedric Francois | — | 25.637K | $11.73 | -$628.81K | OPTION EXERCISE | 1.98% | 1.318115M | Mar 16 - Mar 17 | View |
| Feb 20, 2020 | Cedric Francois | — | 25.637K | $21.40 | -$1.32M | OPTION EXERCISE | 2.02% | 1.292478M | Feb 18 - Feb 19 | View |
| Feb 19, 2020 | Alec Machiels | — | 0 | $22.51 | -$99.20K | OPTION EXERCISE | 0.00% | 671.494K | Feb 14 | View |
| Feb 14, 2020 | Pascal Deschatelets | — | 126.938K | $22.00 | -$4.00M | OPTION EXERCISE | 14.40% | 1.008681M | Feb 12 - Feb 13 | View |
| Feb 12, 2020 | David Watson | — | 8.88K | $23.59 | -$202.46K | GRANT OR AWARD | 20.16% | 52.922K | Feb 10 | View |
| Jan 28, 2020 | David Watson | — | 12K | $21.57 | -$81.35K | OPTION EXERCISE | 37.45% | 44.042K | Jan 27 | View |
| Jan 21, 2020 | Morningside Venture Investments Ltd | — | 540.54K | $37.00 | $20.00M | PURCHASE | 4.50% | 12.556342M | Jan 13 | View |
| Jan 17, 2020 | Cedric Francois | — | -5K | $22.13 | -$1.44M | OPTION EXERCISE | -0.40% | 1.236204M | Jan 15 | View |
| Jan 17, 2020 | Alec Machiels | — | 0 | $22.07 | -$97.00K | OPTION EXERCISE | 0.00% | 670.474K | Jan 15 | View |
| Dec 20, 2019 | A. Sinclair Dunlop | DIRECTOR | -136K | $29.12 | -$3.96M | SELL | -37.70% | 224.728K | Dec 18 - Dec 20 | View |
| Dec 17, 2019 | Cedric Francois | CHIEF EXECUTIVE OFFICER | -5K | $27.95 | -$139.75K | SELL | -0.40% | 1.241204M | Dec 16 | View |
| Nov 18, 2019 | Cedric Francois | CHIEF EXECUTIVE OFFICER | -5K | $27.28 | -$136.41K | SELL | -0.40% | 1.246204M | Nov 15 | View |
| Oct 16, 2019 | Cedric Francois | CHIEF EXECUTIVE OFFICER | -5K | $26.31 | -$131.55K | SELL | -0.40% | 1.251204M | Oct 15 | View |
| Sep 26, 2019 | Pascal Deschatelets | CHIEF OPERATING OFFICER | -21.541K | $25.26 | -$544.06K | SELL | -2.38% | 881.743K | Sep 25 | View |
| Sep 25, 2019 | Pascal Deschatelets | CHIEF OPERATING OFFICER | -42.46K | $24.82 | -$1.05M | SELL | -4.49% | 903.284K | Sep 23 - Sep 24 | View |
| Sep 17, 2019 | Cedric Francois | CHIEF EXECUTIVE OFFICER | -5K | $26.59 | -$132.95K | SELL | -0.40% | 1.256204M | Sep 16 | View |
| Sep 03, 2019 | Timothy Sullivan | CHIEF FINANCIAL OFFICER | 11.699K | $29.71 | $347.63K | BUY | ∞ | 11.699K | Aug 29 | View |
| Aug 16, 2019 | Cedric Francois | CHIEF EXECUTIVE OFFICER | 0 | $14.47 | -$246.61K | SELL-OPTIONS | 0.00% | 1.223699M | Aug 15 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.